Statements (26)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:chemical_compound
|
| gptkbp:administeredBy |
intravenous infusion
|
| gptkbp:alsoKnownAs |
gptkb:Pemetrexed
|
| gptkbp:approvalYear |
2004
|
| gptkbp:approvedBy |
gptkb:FDA
|
| gptkbp:ATCCode |
L01BA04
|
| gptkbp:CASNumber |
137281-23-3
|
| gptkbp:chemicalFormula |
C20H21N5O6
|
| gptkbp:developedBy |
gptkb:Eli_Lilly_and_Company
|
| gptkbp:mechanismOfAction |
gptkb:antifolate_chemotherapy_agent
|
| gptkbp:molecularWeight |
471.41 g/mol
|
| gptkbp:pregnancyCategory |
D (US)
|
| gptkbp:PubChem_CID |
446220
CHEMBL491 |
| gptkbp:sideEffect |
gptkb:anemia
nausea fatigue rash neutropenia |
| gptkbp:UNII |
2Z07MY67F7
|
| gptkbp:usedFor |
treatment of non-small cell lung cancer
treatment of malignant pleural mesothelioma |
| gptkbp:bfsParent |
gptkb:Pemetrexed
gptkb:pemetrexed |
| gptkbp:bfsLayer |
7
|
| http://www.w3.org/2000/01/rdf-schema#label |
LY231514
|